journal article·2025-08

Biofilm penetrating and disrupting polymers to effectively treat endotracheal-tube-associated biofilm infections

Dengwei Yu, Jianyin He, Xu Zhang, Yu Liu, Yiyao Yang, Lichen Yin, Shifang Luan, Haoyu Tang

Acta Biomaterialia· Volume 202
Publisher page

Abstract

Endotracheal-tube-associated biofilm infections (ETTABIs) are directly responsible for most of ventilator-associated pneumonia (VAP), one of the most frequent ICU-acquired infections with up to 13% mortality rates. Herein, we report a new type of biofilm penetrating and disrupting polymers that can be readily used to effectively treat the ETTABIs. A series of mixed-charge brush polymers with dextran main-chains and random copolypeptide side-chains (e.g., Dex-GnEm) were synthesized by a combination of ring-opening polymerization and side-chain or end-group modifications. The effects of α-amino-acid residue compositions, cationic species, and brush-like topological structures on antibiofilm activities were revealed. The top-performing polymer, namely Dex-G15E15 with equivalent guanidinium-modified L-lysine and L-glutamic acid residues showed efficient biofilm penetrating activity significantly outperforming its cationic polymer counterpart. It also showed potent biofilm disrupting activity that over 90% biofilm can be readily eradicated within 24 h. The majority of the bacteria in the biofilms were killed by a membrane disruption mechanism. In addition, Dex-G15E15 could eradicate biofilms formed in endotracheal tubes, inhibit lung infections, and reduce inflammatory responses in a mouse endotracheal intubation model. This work provides a promising antibiofilm reagent candidate to efficiently treat ETTABIs and VAP. STATEMENT OF SIGNIFICANCE: Endotracheal-tube-associated biofilm infections (ETTABIs) present a major challenge in critical care settings, driving persistent infections, antimicrobial resistance, and ventilator-associated pneumonia. Conventional antimicrobial strategies often fail to penetrate biofilms or inadvertently promote bacterial adaptation. Herein, we developed a biofilm penetrating and disrupting polymer to effectively treat ETTABIs. The polymer with brush-like structure and mixed-charge side-chain showed potent biofilm eradication efficacy by efficient penetrating the biofilm, disrupting both biofilm EPS and bacterial membranes, outperforming conventional antibiotics (e.g., ceftazidime, tobramycin, and ciprofloxacin) and linear or brush-like cationic polymers. It also showed potent inhibition of lung infections and reduction of inflammatory responses in a mouse endotracheal intubation model, making it a promising candidate to combat the ETTABIs.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nosocomial Infections in ICU · Pneumonia and Respiratory Infections · Legionella and Acanthamoeba research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Ventilator-associated pneumonia in adults: a narrative review10.1007/s00134-020-05980-0 ↗
2. A systematic scoping review of the cost-impact of ventilator-associated pneumonia (VAP) intervention bundles in intensive care10.1016/j.ajic.2020.11.027 ↗
3. Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges10.1038/s41467-024-50805-z ↗
4. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance10.1016/j.jinf.2016.11.008 ↗
5. Pseudomonas biofilm matrix composition and niche biology10.1111/j.1574-6976.2011.00322.x ↗
6. Escherichia coli exopolysaccharides disrupt Pseudomonas aeruginosa biofilm and increase its antibiotic susceptibility10.1016/j.actbio.2024.07.028 ↗
7. A clinical assessment of the Mucus Shaver: A device to keep the endotracheal tube free from secretions10.1097/CCM.0b013e31822e9fe3 ↗
8. The use of a novel cleaning closed suction system reduces the volume of secretions within the endotracheal tube as assessed by micro-computed tomography: a randomized clinical trial10.1186/s13613-015-0101-9 ↗
9. Antimicrobial Solutions for Endotracheal Tubes in Prevention of Ventilator-Associated Pneumonia10.3390/ma16145034 ↗
10. Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia10.1056/NEJMoa2310307 ↗
11. Eradication of endotracheal tube biofilm by nebulised gentamicin10.1007/s00134-002-1223-8 ↗
12. Treatment of Pseudomonas aeruginosa Biofilm Present in Endotracheal Tubes by Poly-L-Lysine10.1128/AAC.00564-18 ↗
13. Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms10.1038/s41587-022-01584-9 ↗
14. Nanoparticle–Biofilm Interactions: The Role of the EPS Matrix10.1016/j.tim.2019.07.004 ↗
15. Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies10.1039/D1SC05835E ↗
16. High Antibacterial Activity and Selectivity of the Versatile Polysulfoniums that Combat Drug Resistance10.1002/adma.202104402 ↗
17. Disruption of biofilms in periodontal disease through the induction of phase transition by cationic dextrans10.1016/j.actbio.2023.01.008 ↗
18. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles10.2147/IJN.S36111 ↗
19. An anionic and proline-rich peptide prolonged blood circulation of liposomes and evaded accelerated blood clearance after repeated administration10.1016/j.jconrel.2024.12.029 ↗
20. Zwitterionic Biomaterials10.1021/acs.chemrev.2c00344 ↗
21. Biofilm Responsive Zwitterionic Antimicrobial Nanoparticles to Treat Cutaneous Infection10.1021/acs.biomac.1c01274 ↗
22. Self-targeting, zwitterionic micellar dispersants enhance antibiotic killing of infectious biofilms—An intravital imaging study in mice10.1126/sciadv.abb1112 ↗
23. Brush Polymer Coatings with Hydrophilic Main-Chains for Improving Surface Antibacterial Properties10.1021/acsmacrolett.2c00761 ↗
24. Antibacterial brush polypeptide coatings with anionic backbones10.1016/j.actbio.2022.11.020 ↗
25. Impact of Charge Composition and Distribution on the Antibacterial Properties of Polypeptide Coatings10.1021/acsmacrolett.2c00620 ↗
26. Antibacterial and antifouling materials for urinary catheter coatings10.1016/j.actbio.2024.12.040 ↗
27. Helical antimicrobial polypeptides with radial amphiphilicity10.1073/pnas.1507893112 ↗
28. Enantiomeric glycosylated cationic block co-beta-peptides eradicate Staphylococcus aureus biofilms and antibiotic-tolerant persisters10.1038/s41467-019-12702-8 ↗
29. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis10.1016/S0142-9612(02)00445-3 ↗
30. pH-Responsive Polymer–Drug Conjugate: An Effective Strategy to Combat the Antimicrobial Resistance10.1002/adfm.202002655 ↗
31. The MBEC assay system: Multiple equivalent biofilms for antibiotic and biocide susceptibility testing
32. Synthesis and Activity of Biomimetic Biofilm Disruptors10.1021/ja3120955 ↗
33. Fifteen Years of Cell-Penetrating, Guanidinium-Rich Molecular Transporters: Basic Science, Research Tools, and Clinical Applications10.1021/ar4000554 ↗
34. Guanidinium-Perfunctionalized Polyhedral Oligomeric Silsesquioxanes as Highly Potent Antimicrobials against Planktonic Microbes10.1021/acsami.2c16493 ↗
35. Water in bacterial biofilms: pores and channels, storage and transport functions10.1080/1040841X.2021.1962802 ↗
36. Ventilator-associated Pneumonia10.1164/ajrccm.165.7.2105078 ↗
37. Implications of endotracheal tube biofilm for ventilator-associated pneumonia10.1007/s001340051014 ↗
38. Importance of Candida-bacterial polymicrobial biofilms in disease10.1016/j.tim.2011.07.004 ↗
39. The Coexistence of Klebsiella pneumoniae and Candida albicans Enhanced Biofilm Thickness but Induced Less Severe Neutrophil Responses and Less Inflammation in Pneumonia Mice Than K. pneumoniae Alone10.3390/ijms252212157 ↗
40. Influence of twitching and swarming motilities on biofilm formation in Pseudomonas strains10.1007/s00203-017-1344-7 ↗
41. PqsR-dependent and PqsR-independent regulation of motility and biofilm formation by PQS in Pseudomonas aeruginosa PAO110.1002/jobm.201300091 ↗
42. Subinhibitory Concentrations of Biogenic Silver Nanoparticles Affect Motility and Biofilm Formation in Pseudomonas aeruginosa10.3389/fcimb.2021.656984 ↗
43. Pseudomonas aeruginosa AlgR Phosphorylation Modulates Rhamnolipid Production and Motility10.1128/JB.00726-13 ↗
44. Coordination of Swarming Motility, Biosurfactant Synthesis, and Biofilm Matrix Exopolysaccharide Production in Pseudomonas aeruginosa10.1128/AEM.01237-14 ↗
45. Adhesion pilus retraction powers twitching motility in the thermoacidophilic crenarchaeon Sulfolobus acidocaldarius10.1038/s41467-024-49101-7 ↗
46. Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa10.1080/1040841X.2023.2282459 ↗
47. Maximum likelihood estimators for colony-forming units10.1128/spectrum.03946-23 ↗